The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Phase II Trial of High-Dose Conformal Radiation Therapy With Concurrent Hepatic Artery Floxuridine for Unresectable Intrahepatic Malignancies
Open accessAbstract
Purpose: A phase II trial was conducted to determine if high-dose radiation with concurrent hepatic arterial floxuridine would improve survival in patients with unresectable intrahepatic malignancies. Patients and Methods: Three-dimensional conformal high-dose radiation therapy was delivered concurrently with hepatic arterial floxuridine in 128 patients. The radiation dose was based on a normal-tissue complication probability model and subjected the patient to an estimated maximum risk of radiation-induced liver disease of 10% to 15%. The study design provided more than 80% power to detect a two-fold increase in median survival compared with historical controls at a 5% significance level. Results: The median radiation dose delivered was 60.75 Gy (1.5-Gy fractions bid). At a median follow-up time of 16 months (26 months in patients who were alive) the median survival was 15.8 months (95% CI, 12.6 to 18.3 months), significantly longer than in the historical control. The actuarial 3-year survival was 17%. The total dose was the only significant predictor of survival. Primary hepatobiliary tumors had a significantly greater tendency to remain confined to the liver than did colorectal cancer metastases. Overall toxicity was acceptable, with 27 patients (21%) and 11 patients (9%) developing grade 3 and 4 toxicity, respectively, and one treatment-related death. Conclusion: The results suggest that, compared with historical controls, high-dose focal liver irradiation with hepatic artery floxuridine prolongs survival in patients with unresectable chemotherapy-refractory metastatic colorectal cancer and primary hepatobiliary tumors. This provides a rationale for intensification of local therapy for unresectable hepatobiliary cancers and integration of this regimen with newer systemic therapy for patients with colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Tournigand, C., André, T., Achille, E., Lledo, G., Flesh, M., Mery-Mignard, D., Quinaux, E., Couteau, C., Buyse, M., Ganem, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.113 · Cited by 2,915
Abdalla, E. K., Vauthey, J.-N., Ellis, L. M., Ellis, V., Pollock, R., Broglio, K. R., Hess, K., & Curley, S. A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000128305.90650.71 · Cited by 1,750
Cunningham, D., Pyrhönen, S., James, R. D., Punt, C. J., Hickish, T. F., Heikkila, R., Johannesen, T. B., Starkhammar, H., Topham, C. A., Awad, L., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02309-5 · Cited by 1,259
Rougier, P., Van Cutsem, E., Bajetta, E., Niederle, N., Possinger, K., Labianca, R., Navarro, M., Morant, R., Bleiberg, H., Wils, J., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03085-2 · Cited by 992
Kemeny, N., Huang, Y., Cohen, A. M., Shi, W., Conti, J. A., Brennan, M. F., Bertino, J. R., Turnbull, A. D. M., Sullivan, D., Stockman, J., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412702 · Cited by 957
Kutcher, G. J., & Burman, C. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90972-3 · Cited by 912
(1995) · New England Journal of Medicine · doi:10.1056/nejm199505113321903 · Cited by 809
Analysis of radiation-induced liver disease using the Lyman NTCP model
Dawson, L. A., Normolle, D., Balter, J. M., McGinn, C. J., Lawrence, T. S., & Ten Haken, R. K. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02846-8 · Cited by 767
Self-citationMeta-Analysis Group In Cancer (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.5.252 · Cited by 441
Kemeny, N. E., Niedzwiecki, D., Hollis, D. R., Lenz, H.-J., Warren, R. S., Naughton, M. J., Weeks, J. C., Sigurdson, E. R., Herndon, J. E., Zhang, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8166 · Cited by 417
Pelletier, G., Ducreux, M., Gay, F., Luboinski, M., Hagège, H., Thong, D., Van Steenbergen, W., Buffet, C., Rougier, P., Adler, M., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80187-6 · Cited by 396
Dawson, L. A., McGinn, C. J., Normolle, D., Ten Haken, R. K., Walker, S., Ensminger, W., & Lawrence, T. S. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2210 · Cited by 395
Self-citationAndré, T., Tournigand, C., Rosmorduc, O., Provent, S., Maindrault-Goebel, F., Avenin, D., Selle, F., Paye, F., Hannoun, L., Houry, S., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh351 · Cited by 380
Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
Simonetti, R. G., Liberati, A., Angiolini, C., & Pagliaro, L. (1997) · Annals of Oncology · doi:10.1023/a:1008285123736 · Cited by 380
Hepatocellular carcinoma in the United States: Prognostic features, treatment outcome, and survival
Stuart, K. E., Anand, A. J., & Jenkins, R. L. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960601)77:11<2217::aid-cncr6>3.0.co;2-m · Cited by 354
Salem, R., Lewandowski, R., Roberts, C., Goin, J., Thurston, K., Abouljoud, M., & Courtney, A. (2004) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000123319.20705.92 · Cited by 211
Chow, P. K. H., Tai, B.-C., Tan, C.-K., Machin, D., Win, K. M., Johnson, P. J., & Soo, K.-C. (2002) · Hepatology · doi:10.1053/jhep.2002.36824 · Cited by 209
Patt, Y. Z., Hassan, M. M., Aguayo, A., Nooka, A. K., Lozano, R. D., Curley, S. A., Vauthey, J., Ellis, L. M., Schnirer, I. I., Wolff, R. A., et al. (2004) · Cancer · doi:10.1002/cncr.20368 · Cited by 203
Treatment of hepatocellular carcinoma: too many options?
Venook, A. P. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1323 · Cited by 199
Yamada, K., Izaki, K., Sugimoto, K., Mayahara, H., Morita, Y., Yoden, E., Matsumoto, S., Soejima, T., & Sugimura, K. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00434-6 · Cited by 178
Mathurin, Rixe, Carbonell, Bernard, Cluzel, Bellin, Khayat, Opolon, & Poynard (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00286.x · Cited by 164
Cheng, J. C., Chuang, V. P., Cheng, S. H., Huang, A. T., Lin, Y., Cheng, T.-I., Yang, P.-S., You, D., Jian, J. J., Tsai, S. Y., et al. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00462-4 · Cited by 155
Phase II study of S-1 in patients with advanced biliary tract cancer
Ueno, H., Okusaka, T., Ikeda, M., Takezako, Y., & Morizane, C. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602208 · Cited by 149
Kubicka, S., Rudolph, K. L., Tietze, M. K., et al. (2002) · PubMed · Cited by 147
Gemcitabine, 5‐fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma
Alberts, S. R., Alkhatib, H., Mahoney, M. R., et al. (2004) · Cancer · doi:10.1002/cncr.20753 · Cited by 116
Weekly Gemcitabine for the Treatment of Biliary Tract and Gallbladder Cancer
Tsavaris, N. B., Kosmas, C., Gouveris, P., Gennatas, K., Polyzos, A., Mouratidou, D., Tsipras, H., Margaris, H., Papastratis, G., Tzima, E., et al. (2004) · Investigational New Drugs · doi:10.1023/b:drug.0000011797.09549.53 · Cited by 100
Penalized Estimation of Free-Knot Splines
Lindstrom, M. J. (1999) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1999.10474817 · Cited by 97
Outpatient Therapy with Gemcitabine and Docetaxel for Gallbladder, Biliary, and Cholangio-Carcinomas
Kuhn, R., Hribaschek, A., Eichelmann, K., Rudolph, S., Fahlke, J., & Ridwelski, K. (2002) · Investigational New Drugs · doi:10.1023/a:1016209901417 · Cited by 88
Rougier, P. R., Lepille, D., Bennouna, J., Marre, A., Ducreux, M. P., Mignot, L., Hua, A., & Méry-Mignard, D. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf259 · Cited by 86
Knox, J. J., Hedley, D. W., Oza, A. M., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh172 · Cited by 67
Papakostas, P., Kouroussis, C., Androulakis, N., Samelis, G. F., Aravantinos, G., Kalbakis, K., Sarra, E., Souglakos, J., Kakolyris, S., & Georgoulias, V. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00214-3 · Cited by 54
Cited by
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“The benefits of external threedimensional conformal radiotherapy have only been tested in uncontrolled investigations [302].”
BackgroundEASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
(2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.021 · Cited by 1,096
Tse, R. V., Hawkins, M., Lockwood, G., Kim, J. J., Cummings, B., Knox, J., Sherman, M., & Dawson, L. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3529 · Cited by 589
Self-citationPhase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases
Lee, M. T., Kim, J. J., Dinniwell, R., Brierley, J., Lockwood, G., Wong, R., Cummings, B., Ringash, J., Tse, R. V., Knox, J. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.0600 · Cited by 473
Self-citationHong, T. S., Wo, J. Y., Yeap, B. Y., Ben-Josef, E., McDonnell, E. I., Blaszkowsky, L. S., Kwak, E. L., Allen, J. N., Clark, J. W., Goyal, L., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.2710 · Cited by 472
Self-citation
Metadata
- Authors
- Ben-Josef, E., Normolle, D., Ensminger, W. D., Walker, S., Tatro, D., Ten Haken, R. K., Knol, J., Dawson, L. A., Pan, C., & Lawrence, T. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-12-01
- Volume
- 23
- Issue
- 34
- Pages
- 8739-8747
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2090483604
- Cited by
- 355
- References
- 33
- FWCI
- 7.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.